Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.
  • 2023 Community Survey Report Now Available

  • Innovators in Nuclear Medicine

  • Delivering Innovative Full-Service Solutions in Nuclear Medicine


Bold Vision, History of Innovation

Our vision at BWXT Medical is to become a global leading company in Nuclear Medicine; developing, manufacturing and supplying products for diagnostic imaging and radiotherapeutic treatments.  We manufacture medical isotopes, pharmaceuticals and medical devices, and partner with companies developing new drugs.

Our customers include Life Science companies, radiopharmacies, hospitals, researchers, and ultimately patients. Our commitment to providing hope and health for patients is unwavering, as is our dedication to safety and quality for every aspect of our business.

Our growing product and service portfolio is backed by a proven track record gained from over 40 years of experience.

Quality Products and Services, Unwavering Commitment to Nuclear Medicine

BWXT Medical meets the demand for critical nuclear medicine products by combining our innovative resources with strategic relationships. We are completing milestones on our path to commercializing our new Technetium-99m generator, and have programs and partnerships in place to enable the development and commercialization of new radiopharmaceutical products.

Contract Development and Manufacturing

BWXT Medical is a trusted source for the development and manufacturer of nuclear medicine for biotechnology, life sciences, pharmaceutical companies and academia partners, such as TheraSphere™, a device manufactured for Boston Scientific Corporation. TheraSphere™ is a targeted hepatocellular carcinoma (HCC) therapy consisting of glass microspheres containing radioactive Yttrium-90 (Y-90) and has been manufactured at our Ottawa, Ontario facility for over 20 years.